Global Malaria News
Do you have a questions about malaria? Ask our experts!
Proposals to fight malaria by 'driving' genes that slow its spread through mosquitoes is a high-risk, high-reward technology that presents a challenge to science journalists, according to a new report aimed at stimulating a fruitful, realistic public discussion of 'post-normal' science and technology.
Scientists have provided, for the first time, evidence which links the ability of red blood cells infected with the malaria parasite to bind to the cells lining the blood vessels of the brain, with the clinical syndrome cerebral malaria.
Categories: Special Feature
A vaccine against fatal pregnancy malaria shows promising results in the first tests in humans. The new study has taken a vaccine all the way from discovery of a mechanism through development and production to clinical trials in humans.
A newly discovered protein that is crucial for egg production in mosquitoes opens a possibility for 'mosquito birth control.' The approach might offer a way to reduce mosquito populations in areas of human disease transmission without harming beneficial insects such as honey bees.
Researchers have looked at the efficacy of using a novel artemisinin-based combination therapy (ACT), pyronaridine-artesunate, to treat malaria in areas where resistance to other ACTs is becoming a problem. The analysis finds it at least as effective as the currently used ACTs, if not better.
Insecticide-infused mosquito netting is in widespread use around the world to limit the spread of mosquito-borne diseases, such as malaria. Researchers have now come up with a technique that measures how much insecticide is found on the surface of these nets -- paving the way for efforts to determine how long the nets are effective.
Question: Does malaria treatment, especially with paluta injection cause insomnia. I have experienced this twice. Answer: If you are referring to injection with artemether (sold as Paluther), then yes, trouble sleeping has been recorded as a possible side effect. However, it should not persist for long after the medication has been administered, so you should consult […]
Researchers have developed novel ferrocene-based molecules that impair the malaria parasite's metabolic function leading to parasite death.
Currently, few antimalarial treatments exist that effectively kill liver-stage malaria parasite Plasmodium vivax, which can lay dormant for months or even years. Researchers have reported a new drug that could eliminate liver-stage malaria parasites completely. Using an insect virus, known as a baculovirus, the researchers investigated the ability of baculovirus to mediate innate immunity against malaria infection. This work could pave the way for developing new and more effective antimalarial treatments.
They approach with the telltale sign -- a high-pitched whine. It's a warning that you are a mosquito's next meal. But that mosquito might carry a virus, and now the virus is in you. Now, with the help of state-of-the-art technology, researchers can see how a virus moves within a mosquito's body, which could lead to the prevention of mosquitoes transmitting diseases.
Researchers spent two years testing chemical compounds for their ability to inhibit the malaria parasite at an earlier stage in its lifecycle than most current drugs, revealing a new set of chemical starting points for the first drugs to prevent malaria instead of just treating the symptoms.
Researchers have generated six Zika virus antibodies that could be used to test for and possibly treat a mosquito-borne disease that has infected more than 1.5 million people worldwide.
Conversion from the asexual to the sexual phase of the malaria parasite is necessary for its transmission to the mosquito.
Malaria parasites know good times from bad and plan their offspring accordingly, scientists have found, in a development that could inform new treatments.
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a new study. The results also indicated that early exposure to the parasite does not affect the risk of developing the disease, although it could affect the parasite-specific immune response later in life.
Mosquitoes of the genus Anopheles are well known as primary vectors of malaria. But a new study suggests that Anopheles species, including some found in the United States, also are capable of carrying and transmitting an emerging pathogen, Mayaro virus, which has caused outbreaks of disease in South America and the Caribbean.
A new study shows for the first time the impact that climate change is having on the rate in which mosquitoes diversify, and what this might mean for human health in the future.
As the global battle against malaria stalls, scientists may be adding a novel tool to the fight: sniffer dogs. In recent tests trained sniffer dogs successfully diagnosed malaria infections simply by sniffing samples from socks worn briefly by children from a malaria endemic area of West Africa, according to a new study.